| Bioactivity | LL-K9-3 is a potent small-molecule degrader of CDK9-cyclin T1. LL-K9-3 has anti-proliferative and pro-apoptotic activities and suppresses downstream signaling of CDK9 and AR. Moreover, LL-K9-3 inhibits AR and Myc-driven oncogenic transcriptional programs[1]. |
| Name | LL-K9-3 |
| CAS | 2809353-52-2 |
| Formula | C31H49N5O6S3 |
| Molar Mass | 683.95 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li J, et al. Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer. J Med Chem. 2022 Aug 25;65(16):11034-11057. |
LL-K9-3
CAS: 2809353-52-2 F: C31H49N5O6S3 W: 683.95
LL-K9-3 is a potent small-molecule degrader of CDK9-cyclin T1. LL-K9-3 has anti-proliferative and pro-apoptotic activiti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.